lawmakers should revisit that idea when lepage is no longer in office next year..
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done...
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...december 7, 2017.español... ..